Your suppliers have risk you cannot see. Why? Because the data lives in systems that never speak to each other.
Pharmaceutical supply chains generate vast amounts of quality and regulatory data, but most organizations manage it in silos. Audit observations live in one system. FDA inspection outcomes live in another. Recall history, adverse event reports, and ontime delivery performance each occupy their own island. The result: quality teams spend 80% of their time gathering data and only 20% acting on it.
This case study documents a predictive risk intelligence framework applied across a 20-site CMO and API portfolio. By integrating external regulatory signals with internal quality data through a five-pillar composite risk model, the framework enables quality teams to move from reactive firefighting to proactive, data-driven supplier oversight, identifying convergent risk before it reaches patients.
© An Imprint of coreinteltech | All rights reserved | Privacy Policy